• Clinical Insights: March 9, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Azstarys™ (dexmethylphenidate and serdexmethylphenidate) Capsules – New Drug Approval – March 2, 2021 – KemPharm, Inc., a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs,… Read more »

  • Clinical Insights: March 2, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval Nulibry™ (fosdenopterin) Injection – New Drug Approval – February 26, 2021 – The U.S. Food and Drug Administration approved Nulibry™ (fosdenopterin) for injection to reduce the risk of… Read more »

  • Clinical Insights: February 23, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy marketplace. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval Entresto® (sacubitril and valsartan) Tablets – New Approved Indication – February 16, 2021 – Novartis announced… Read more »

  • Clinical Insights: February 16, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval CoselaTM (trilaciclib) – New Drug Approval – February 12, 2021 – The U.S. Food and Drug Administration approved CoselaTM (trilaciclib) as the first therapy in its class to… Read more »

  • Clinical Insights: February 9, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval BreyanziTM (lisocabtagene maraleucel) – New Drug Approval – February 5, 2021 – The U.S. Food and Drug Administration approved BreyanziTM (lisocabtagene maraleucel), a cell-based gene therapy to treat… Read more »

  • Clinical Insights: February 2, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval Plegridy® (peginterferon beta-1a) Injection – New Approved Route of Administration – January 29, 2021 – Biogen… Read more »

  • Let’s Connect! 340B Coalition Winter Conference

      RxStrategies is a proud Pinnacle Partner of the 2021 340B Coalition Winter Conference, February 16-24. Our team members are ready to connect, arrange a dashboard analytics demo and discuss our 340B compliance solutions. – Connect with us throughout the event and visit our virtual booth. – Attend our Vendor Demo on 2/16 from 1:15 – 2:15… Read more »

  • Clinical Insights: January 26, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval LupkynisTM (voclosporin) Capsules – New Drug Approval – January 22, 2021 – Aurinia Pharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LupkynistTM (voclosporin)… Read more »

  • Clinical Insights: January 19, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval Enhertu® (fam-trastuzumab deruxtecan-nxki) Injection – New Approved Indication – January 15, 2021 – Daiichi Sankyo Company,… Read more »

  • Clinical Insights: January 12, 2021

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New/Updated Drug Shortage January 11, 2021 Dexmedetomidine Injection (Currently in Shortage) Tacrolimus Capsules… Read more »